JP2000516588A - 細胞増殖阻害のための置換ビスインドリルマレイミド - Google Patents
細胞増殖阻害のための置換ビスインドリルマレイミドInfo
- Publication number
- JP2000516588A JP2000516588A JP10508452A JP50845298A JP2000516588A JP 2000516588 A JP2000516588 A JP 2000516588A JP 10508452 A JP10508452 A JP 10508452A JP 50845298 A JP50845298 A JP 50845298A JP 2000516588 A JP2000516588 A JP 2000516588A
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- indol
- alkyl
- compound
- nitro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 230000010261 cell growth Effects 0.000 title claims description 4
- DQYBRTASHMYDJG-UHFFFAOYSA-N Bisindolylmaleimide IV Natural products C1=CC=C2C(C=3C(=O)NC(C=3C=3C4=CC=CC=C4NC=3)=O)=CNC2=C1 DQYBRTASHMYDJG-UHFFFAOYSA-N 0.000 title description 4
- 150000003924 bisindolylmaleimides Chemical class 0.000 title description 2
- 230000005764 inhibitory process Effects 0.000 title description 2
- -1 nitro, amino Chemical group 0.000 claims abstract description 165
- 150000001875 compounds Chemical class 0.000 claims abstract description 130
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 74
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 48
- 239000001257 hydrogen Substances 0.000 claims abstract description 41
- 150000003839 salts Chemical class 0.000 claims abstract description 35
- 125000003118 aryl group Chemical group 0.000 claims abstract description 31
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 24
- 150000002367 halogens Chemical class 0.000 claims abstract description 24
- 239000002253 acid Substances 0.000 claims abstract description 21
- 125000004093 cyano group Chemical group *C#N 0.000 claims abstract description 21
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 20
- 125000004414 alkyl thio group Chemical group 0.000 claims abstract description 20
- 125000004442 acylamino group Chemical group 0.000 claims abstract description 18
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims abstract description 18
- 150000002431 hydrogen Chemical class 0.000 claims abstract description 18
- 150000007513 acids Chemical class 0.000 claims abstract description 14
- 125000004663 dialkyl amino group Chemical group 0.000 claims abstract description 13
- 125000001188 haloalkyl group Chemical group 0.000 claims abstract description 11
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 10
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims abstract description 9
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims abstract description 9
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract description 8
- 125000004104 aryloxy group Chemical group 0.000 claims abstract description 8
- 150000001540 azides Chemical class 0.000 claims abstract description 8
- 150000007514 bases Chemical class 0.000 claims abstract description 8
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 claims abstract description 8
- 125000005135 aryl sulfinyl group Chemical group 0.000 claims abstract description 7
- 229910019142 PO4 Inorganic materials 0.000 claims abstract description 6
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims abstract description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims abstract description 6
- 239000010452 phosphate Substances 0.000 claims abstract description 6
- 239000000651 prodrug Substances 0.000 claims abstract description 6
- 229940002612 prodrug Drugs 0.000 claims abstract description 6
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims abstract description 6
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 4
- 125000000304 alkynyl group Chemical group 0.000 claims abstract description 4
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 4
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 17
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 12
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 11
- AZRRZGIBBLWSSQ-UHFFFAOYSA-N 4-ethyl-7-phenyl-3,5-diazabicyclo[2.2.2]octane-2,6-dione Chemical compound N1C(=O)C2C(=O)NC1(CC)CC2C1=CC=CC=C1 AZRRZGIBBLWSSQ-UHFFFAOYSA-N 0.000 claims description 6
- 125000002252 acyl group Chemical group 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 6
- 125000003282 alkyl amino group Chemical group 0.000 claims description 4
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims description 4
- 230000002401 inhibitory effect Effects 0.000 claims description 4
- FPZWZCWUIYYYBU-UHFFFAOYSA-N 2-(2-ethoxyethoxy)ethyl acetate Chemical group CCOCCOCCOC(C)=O FPZWZCWUIYYYBU-UHFFFAOYSA-N 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims description 3
- 241001024304 Mino Species 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 abstract description 4
- 239000003795 chemical substances by application Substances 0.000 abstract description 3
- 125000004103 aminoalkyl group Chemical group 0.000 abstract description 2
- 230000001028 anti-proliverative effect Effects 0.000 abstract description 2
- 201000011510 cancer Diseases 0.000 abstract description 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract description 2
- 125000004945 acylaminoalkyl group Chemical group 0.000 abstract 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 abstract 1
- 125000005078 alkoxycarbonylalkyl group Chemical group 0.000 abstract 1
- 125000005154 alkyl sulfonyl amino alkyl group Chemical group 0.000 abstract 1
- 125000006350 alkyl thio alkyl group Chemical group 0.000 abstract 1
- 125000005097 aminocarbonylalkyl group Chemical group 0.000 abstract 1
- 125000004181 carboxyalkyl group Chemical group 0.000 abstract 1
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 abstract 1
- 125000005358 mercaptoalkyl group Chemical group 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 67
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 39
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 36
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 34
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 33
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 33
- 239000000203 mixture Substances 0.000 description 32
- 150000002148 esters Chemical class 0.000 description 28
- 239000000243 solution Substances 0.000 description 26
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 24
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 23
- 238000000034 method Methods 0.000 description 21
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 18
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 18
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 18
- 239000011541 reaction mixture Substances 0.000 description 17
- 235000019439 ethyl acetate Nutrition 0.000 description 15
- 239000002904 solvent Substances 0.000 description 14
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 13
- 238000002844 melting Methods 0.000 description 11
- 230000008018 melting Effects 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 239000007787 solid Substances 0.000 description 11
- 125000001424 substituent group Chemical group 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 9
- 235000019341 magnesium sulphate Nutrition 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 9
- 239000002585 base Substances 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- 239000000460 chlorine Substances 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- 125000006239 protecting group Chemical group 0.000 description 7
- 238000010992 reflux Methods 0.000 description 7
- AYGFFYXMDIOSFO-UHFFFAOYSA-N 1-methyl-6-nitroindole Chemical compound C1=C([N+]([O-])=O)C=C2N(C)C=CC2=C1 AYGFFYXMDIOSFO-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 229910000104 sodium hydride Inorganic materials 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000012044 organic layer Substances 0.000 description 5
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 239000012346 acetyl chloride Substances 0.000 description 4
- 238000004440 column chromatography Methods 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 238000003818 flash chromatography Methods 0.000 description 4
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 150000003233 pyrroles Chemical class 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 3
- VTERTDXYBJGLGB-UHFFFAOYSA-N 2-(1-methyl-6-nitroindol-3-yl)-2-oxoacetyl chloride Chemical compound C1=C([N+]([O-])=O)C=C2N(C)C=C(C(=O)C(Cl)=O)C2=C1 VTERTDXYBJGLGB-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 3
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 3
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 3
- 150000004678 hydrides Chemical class 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- CFOAUYCPAUGDFF-UHFFFAOYSA-N tosmic Chemical compound CC1=CC=C(S(=O)(=O)C[N+]#[C-])C=C1 CFOAUYCPAUGDFF-UHFFFAOYSA-N 0.000 description 3
- MIMYTSWNVBMNRH-UHFFFAOYSA-N 1h-indol-6-amine Chemical compound NC1=CC=C2C=CNC2=C1 MIMYTSWNVBMNRH-UHFFFAOYSA-N 0.000 description 2
- LGVGGGFVASYZIB-UHFFFAOYSA-N 2-(1,5-dimethylindol-3-yl)-2-oxoacetyl chloride Chemical compound CC1=CC=C2N(C)C=C(C(=O)C(Cl)=O)C2=C1 LGVGGGFVASYZIB-UHFFFAOYSA-N 0.000 description 2
- ZRVSMBXXORLZAV-UHFFFAOYSA-N 2-(1,6-dimethylindol-3-yl)acetamide Chemical compound CC1=CC=C2C(CC(N)=O)=CN(C)C2=C1 ZRVSMBXXORLZAV-UHFFFAOYSA-N 0.000 description 2
- MBMZNVBRAUARDX-UHFFFAOYSA-N 2-(4-methoxy-1-methylindol-3-yl)-2-oxoacetyl chloride Chemical compound COC1=CC=CC2=C1C(C(=O)C(Cl)=O)=CN2C MBMZNVBRAUARDX-UHFFFAOYSA-N 0.000 description 2
- FMDDEAHFVZRKNJ-UHFFFAOYSA-N 2-(6-acetamido-1-methylindol-3-yl)-2-oxoacetyl chloride Chemical compound CC(=O)NC1=CC=C2C(C(=O)C(Cl)=O)=CN(C)C2=C1 FMDDEAHFVZRKNJ-UHFFFAOYSA-N 0.000 description 2
- LSMNIAWTHOCTKL-UHFFFAOYSA-N 2-(6-fluoro-1-methylindol-3-yl)-2-oxoacetyl chloride Chemical compound C1=C(F)C=C2N(C)C=C(C(=O)C(Cl)=O)C2=C1 LSMNIAWTHOCTKL-UHFFFAOYSA-N 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- AFNRHTISODTULX-UHFFFAOYSA-N 3-(6-amino-1-methylindol-3-yl)-4-(6-fluoro-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound C12=CC=C(N)C=C2N(C)C=C1C1=C(C=2C3=CC=C(F)C=C3N(C)C=2)C(=O)NC1=O AFNRHTISODTULX-UHFFFAOYSA-N 0.000 description 2
- RCMUCJKZDTYCCT-UHFFFAOYSA-N 3-(6-amino-1-methylindol-3-yl)-4-(6-methoxy-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound NC1=CC=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)OC)=CN(C)C2=C1 RCMUCJKZDTYCCT-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- JTEFJNIWWXTBMP-UHFFFAOYSA-N 6-methoxy-1h-indole-3-carbaldehyde Chemical compound COC1=CC=C2C(C=O)=CNC2=C1 JTEFJNIWWXTBMP-UHFFFAOYSA-N 0.000 description 2
- PSWCIARYGITEOY-UHFFFAOYSA-N 6-nitro-1h-indole Chemical compound [O-][N+](=O)C1=CC=C2C=CNC2=C1 PSWCIARYGITEOY-UHFFFAOYSA-N 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- 241001676573 Minium Species 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 150000004292 cyclic ethers Chemical class 0.000 description 2
- 238000010511 deprotection reaction Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000008298 dragée Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- CEIPQQODRKXDSB-UHFFFAOYSA-N ethyl 3-(6-hydroxynaphthalen-2-yl)-1H-indazole-5-carboximidate dihydrochloride Chemical compound Cl.Cl.C1=C(O)C=CC2=CC(C3=NNC4=CC=C(C=C43)C(=N)OCC)=CC=C21 CEIPQQODRKXDSB-UHFFFAOYSA-N 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- 238000007429 general method Methods 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- 125000001041 indolyl group Chemical group 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- WIDPUEXDDQAFTO-UHFFFAOYSA-N methyl 6-methylsulfanyl-1h-indole-2-carboxylate Chemical compound C1=C(SC)C=C2NC(C(=O)OC)=CC2=C1 WIDPUEXDDQAFTO-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- UPOQSRSOENMVDY-UHFFFAOYSA-N n,1-dimethylindol-6-amine Chemical compound CNC1=CC=C2C=CN(C)C2=C1 UPOQSRSOENMVDY-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- FWRAEYXMASVQTF-UHFFFAOYSA-N propan-2-yl 2-(1-methyl-6-nitroindol-3-yl)ethanimidate;hydrochloride Chemical compound Cl.[O-][N+](=O)C1=CC=C2C(CC(=N)OC(C)C)=CN(C)C2=C1 FWRAEYXMASVQTF-UHFFFAOYSA-N 0.000 description 2
- MJEXPQIFDCDILO-UHFFFAOYSA-N propan-2-yl 2-(6-ethoxy-1-methylindol-3-yl)ethanimidate;hydrochloride Chemical compound Cl.CCOC1=CC=C2C(CC(=N)OC(C)C)=CN(C)C2=C1 MJEXPQIFDCDILO-UHFFFAOYSA-N 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 125000004001 thioalkyl group Chemical group 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- MYZAXBZLEILEBR-RVFOSREFSA-N (2S)-1-[(2S,3R)-2-[[(2R)-2-[[2-[[(2S)-2-[(2-aminoacetyl)amino]-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-3-sulfopropanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid Chemical compound C[C@@H](O)[C@H](NC(=O)[C@H](CS(O)(=O)=O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)CN)C(=O)N1CCC[C@H]1C(O)=O MYZAXBZLEILEBR-RVFOSREFSA-N 0.000 description 1
- BDNKZNFMNDZQMI-UHFFFAOYSA-N 1,3-diisopropylcarbodiimide Chemical compound CC(C)N=C=NC(C)C BDNKZNFMNDZQMI-UHFFFAOYSA-N 0.000 description 1
- AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 description 1
- XDZKJWVLSJKLST-UHFFFAOYSA-N 1-amino-3,4-bis(1h-indol-2-yl)pyrrole-2,5-dione Chemical compound C1=CC=C2NC(C=3C(=O)N(C(C=3C=3NC4=CC=CC=C4C=3)=O)N)=CC2=C1 XDZKJWVLSJKLST-UHFFFAOYSA-N 0.000 description 1
- DZXIYFTZNCKWLG-UHFFFAOYSA-N 1-methyl-3-[4-(1-methyl-6-nitroindol-3-yl)-2,5-dioxopyrrol-3-yl]indole-6-carbonitrile Chemical compound C12=CC=C(C#N)C=C2N(C)C=C1C1=C(C=2C3=CC=C(C=C3N(C)C=2)[N+]([O-])=O)C(=O)NC1=O DZXIYFTZNCKWLG-UHFFFAOYSA-N 0.000 description 1
- FUPIEEZTCMDMTO-UHFFFAOYSA-N 1-methyl-7-nitroindole Chemical compound C1=CC([N+]([O-])=O)=C2N(C)C=CC2=C1 FUPIEEZTCMDMTO-UHFFFAOYSA-N 0.000 description 1
- MTZOSTDWLSSPHA-UHFFFAOYSA-N 1-methylindol-6-amine Chemical compound C1=C(N)C=C2N(C)C=CC2=C1 MTZOSTDWLSSPHA-UHFFFAOYSA-N 0.000 description 1
- NKDOUVHMIPLZFP-UHFFFAOYSA-N 1-methylindol-6-amine;hydrochloride Chemical compound Cl.C1=C(N)C=C2N(C)C=CC2=C1 NKDOUVHMIPLZFP-UHFFFAOYSA-N 0.000 description 1
- WBYHCAAPHDLMGA-UHFFFAOYSA-N 2,2,2-trifluoro-n-(1-methylindol-6-yl)acetamide Chemical compound C1=C(NC(=O)C(F)(F)F)C=C2N(C)C=CC2=C1 WBYHCAAPHDLMGA-UHFFFAOYSA-N 0.000 description 1
- NRKYWOKHZRQRJR-UHFFFAOYSA-N 2,2,2-trifluoroacetamide Chemical compound NC(=O)C(F)(F)F NRKYWOKHZRQRJR-UHFFFAOYSA-N 0.000 description 1
- RSUCXQRUMFUPLX-UHFFFAOYSA-N 2-(1,6-dimethylindol-3-yl)-2-oxoacetyl chloride Chemical compound CC1=CC=C2C(C(=O)C(Cl)=O)=CN(C)C2=C1 RSUCXQRUMFUPLX-UHFFFAOYSA-N 0.000 description 1
- OOHMTPJLHLKWLK-UHFFFAOYSA-N 2-(1-methyl-6-methylsulfanylindol-3-yl)-2-oxoacetyl chloride Chemical compound CSC1=CC=C2C(C(=O)C(Cl)=O)=CN(C)C2=C1 OOHMTPJLHLKWLK-UHFFFAOYSA-N 0.000 description 1
- RYYWLPXBQVMKDQ-UHFFFAOYSA-N 2-(1-methyl-6-nitroindol-3-yl)acetamide Chemical compound C1=C([N+]([O-])=O)C=C2N(C)C=C(CC(O)=N)C2=C1 RYYWLPXBQVMKDQ-UHFFFAOYSA-N 0.000 description 1
- KSXPVMSAYPBSAW-UHFFFAOYSA-N 2-(1-methyl-6-nitroindol-3-yl)acetonitrile Chemical group C1=C([N+]([O-])=O)C=C2N(C)C=C(CC#N)C2=C1 KSXPVMSAYPBSAW-UHFFFAOYSA-N 0.000 description 1
- QBQCDHCCEVMSHU-UHFFFAOYSA-N 2-(5-chloro-1-methylindol-3-yl)-2-oxoacetyl chloride Chemical compound ClC1=CC=C2N(C)C=C(C(=O)C(Cl)=O)C2=C1 QBQCDHCCEVMSHU-UHFFFAOYSA-N 0.000 description 1
- OYAVWZCFDJYNFB-UHFFFAOYSA-N 2-(6-azido-1-methylindol-3-yl)-2-oxoacetyl chloride Chemical compound C1=C(N=[N+]=[N-])C=C2N(C)C=C(C(=O)C(Cl)=O)C2=C1 OYAVWZCFDJYNFB-UHFFFAOYSA-N 0.000 description 1
- WEFXNTLSKCMIME-UHFFFAOYSA-N 2-(6-cyano-1-methylindol-3-yl)-2-oxoacetyl chloride Chemical compound C1=C(C#N)C=C2N(C)C=C(C(=O)C(Cl)=O)C2=C1 WEFXNTLSKCMIME-UHFFFAOYSA-N 0.000 description 1
- GHDQKPBSEZCOJO-UHFFFAOYSA-N 2-(6-ethoxy-1-methylindol-3-yl)-2-oxoacetyl chloride Chemical compound CCOC1=CC=C2C(C(=O)C(Cl)=O)=CN(C)C2=C1 GHDQKPBSEZCOJO-UHFFFAOYSA-N 0.000 description 1
- LNUOZWIFGAJCAE-UHFFFAOYSA-N 2-(6-methoxy-1-methylindol-3-yl)acetonitrile Chemical compound COC1=CC=C2C(CC#N)=CN(C)C2=C1 LNUOZWIFGAJCAE-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- KZLVMCGDHNDZEL-UHFFFAOYSA-N 2-[1-methyl-6-[(2,2,2-trifluoroacetyl)amino]indol-3-yl]-2-oxoacetyl chloride Chemical compound C1=C(NC(=O)C(F)(F)F)C=C2N(C)C=C(C(=O)C(Cl)=O)C2=C1 KZLVMCGDHNDZEL-UHFFFAOYSA-N 0.000 description 1
- SCVJRXQHFJXZFZ-KVQBGUIXSA-N 2-amino-9-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3h-purine-6-thione Chemical compound C1=2NC(N)=NC(=S)C=2N=CN1[C@H]1C[C@H](O)[C@@H](CO)O1 SCVJRXQHFJXZFZ-KVQBGUIXSA-N 0.000 description 1
- NEMOFKXFUODUAQ-UHFFFAOYSA-N 3,4-bis(1-methyl-6-nitroindol-3-yl)pyrrole-2,5-dione Chemical compound C12=CC=C([N+]([O-])=O)C=C2N(C)C=C1C1=C(C=2C3=CC=C(C=C3N(C)C=2)[N+]([O-])=O)C(=O)NC1=O NEMOFKXFUODUAQ-UHFFFAOYSA-N 0.000 description 1
- WPZQPDYNVHHVDB-UHFFFAOYSA-N 3,4-bis(5-methoxy-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound C1=C(OC)C=C2C(C3=C(C(NC3=O)=O)C3=CN(C)C4=CC=C(C=C43)OC)=CN(C)C2=C1 WPZQPDYNVHHVDB-UHFFFAOYSA-N 0.000 description 1
- VATAIYAPPIYGCK-UHFFFAOYSA-N 3,4-bis(6-amino-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound C12=CC=C(N)C=C2N(C)C=C1C1=C(C=2C3=CC=C(N)C=C3N(C)C=2)C(=O)NC1=O VATAIYAPPIYGCK-UHFFFAOYSA-N 0.000 description 1
- KSDKEVVQNNJDER-UHFFFAOYSA-N 3,4-bis(6-amino-1h-indol-3-yl)pyrrole-2,5-dione Chemical compound NC1=CC=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4NC=3)N)=CNC2=C1 KSDKEVVQNNJDER-UHFFFAOYSA-N 0.000 description 1
- DHHHPVHEKHYOEU-UHFFFAOYSA-N 3,4-bis(6-methoxy-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound COC1=CC=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)OC)=CN(C)C2=C1 DHHHPVHEKHYOEU-UHFFFAOYSA-N 0.000 description 1
- SOZPHISDUAAINE-UHFFFAOYSA-N 3-(1,5-dimethylindol-3-yl)-4-(1,6-dimethylindol-3-yl)pyrrole-2,5-dione Chemical compound CC1=CC=C2C(C3=C(C(NC3=O)=O)C3=CN(C)C4=CC=C(C=C43)C)=CN(C)C2=C1 SOZPHISDUAAINE-UHFFFAOYSA-N 0.000 description 1
- AEUOPGMQEZUHRH-UHFFFAOYSA-N 3-(1-methyl-5-nitroindol-3-yl)-4-(1-methyl-6-nitroindol-3-yl)pyrrole-2,5-dione Chemical compound C12=CC([N+]([O-])=O)=CC=C2N(C)C=C1C1=C(C=2C3=CC=C(C=C3N(C)C=2)[N+]([O-])=O)C(=O)NC1=O AEUOPGMQEZUHRH-UHFFFAOYSA-N 0.000 description 1
- GTVGZOSMUXVPFP-UHFFFAOYSA-N 3-(1-methyl-6-methylsulfanylindol-3-yl)-4-(1-methyl-6-nitroindol-3-yl)pyrrole-2,5-dione Chemical compound [O-][N+](=O)C1=CC=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)SC)=CN(C)C2=C1 GTVGZOSMUXVPFP-UHFFFAOYSA-N 0.000 description 1
- AUHXDRWVPXMGPO-UHFFFAOYSA-N 3-(1-methyl-6-nitroindol-3-yl)-4-(1-methyl-6-phenylmethoxyindol-3-yl)pyrrole-2,5-dione Chemical compound C1=C2N(C)C=C(C=3C(NC(=O)C=3C=3C4=CC=C(C=C4N(C)C=3)[N+]([O-])=O)=O)C2=CC=C1OCC1=CC=CC=C1 AUHXDRWVPXMGPO-UHFFFAOYSA-N 0.000 description 1
- BCPLCKLBFNZFHF-UHFFFAOYSA-N 3-(1-methyl-6-nitroindol-3-yl)-4-(1-methyl-7-nitroindol-3-yl)pyrrole-2,5-dione Chemical compound C12=CC=C([N+]([O-])=O)C=C2N(C)C=C1C1=C(C=2C3=CC=CC(=C3N(C)C=2)[N+]([O-])=O)C(=O)NC1=O BCPLCKLBFNZFHF-UHFFFAOYSA-N 0.000 description 1
- DENNIJDJQGTSQS-UHFFFAOYSA-N 3-(2-amino-1,6-dimethylindol-3-yl)-4-(6-methoxy-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound CC1=CC=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)OC)=C(N)N(C)C2=C1 DENNIJDJQGTSQS-UHFFFAOYSA-N 0.000 description 1
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 1
- IALHCIPMPHGBEF-UHFFFAOYSA-N 3-(4-bromo-1-methylindol-3-yl)-4-(6-ethoxy-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound C1=CC(Br)=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)OCC)=CN(C)C2=C1 IALHCIPMPHGBEF-UHFFFAOYSA-N 0.000 description 1
- LECJABKVHGIYHA-UHFFFAOYSA-N 3-(4-fluoro-1-methylindol-3-yl)-4-(1-methyl-6-nitroindol-3-yl)pyrrole-2,5-dione Chemical compound C12=CC=C([N+]([O-])=O)C=C2N(C)C=C1C1=C(C=2C3=C(F)C=CC=C3N(C)C=2)C(=O)NC1=O LECJABKVHGIYHA-UHFFFAOYSA-N 0.000 description 1
- PTGHTIJBKJRRTB-UHFFFAOYSA-N 3-(4-fluoro-1-methylindol-3-yl)-4-(6-methoxy-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound C1=CC(F)=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)OC)=CN(C)C2=C1 PTGHTIJBKJRRTB-UHFFFAOYSA-N 0.000 description 1
- YCKYELGJROPRNG-UHFFFAOYSA-N 3-(4-methoxy-1-methylindol-3-yl)-4-(1-methyl-6-nitroindol-3-yl)pyrrole-2,5-dione Chemical compound [O-][N+](=O)C1=CC=C2C(C3=C(C(NC3=O)=O)C3=CN(C)C=4C=CC=C(C3=4)OC)=CN(C)C2=C1 YCKYELGJROPRNG-UHFFFAOYSA-N 0.000 description 1
- XCUQCCVOZUVKOE-UHFFFAOYSA-N 3-(4-methoxy-1-methylindol-3-yl)-4-(5-methoxy-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound C1=CC(OC)=C2C(C3=C(C(NC3=O)=O)C3=CN(C)C4=CC=C(C=C43)OC)=CN(C)C2=C1 XCUQCCVOZUVKOE-UHFFFAOYSA-N 0.000 description 1
- RXAQTWCQDDZRRJ-UHFFFAOYSA-N 3-(4-methoxy-1-methylindol-3-yl)-4-(6-methoxy-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound C1=CC(OC)=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)OC)=CN(C)C2=C1 RXAQTWCQDDZRRJ-UHFFFAOYSA-N 0.000 description 1
- HIKITLLOKBXDAM-UHFFFAOYSA-N 3-(5-chloro-1-methylindol-3-yl)-4-(1-methyl-6-nitroindol-3-yl)pyrrole-2,5-dione Chemical compound C12=CC(Cl)=CC=C2N(C)C=C1C1=C(C=2C3=CC=C(C=C3N(C)C=2)[N+]([O-])=O)C(=O)NC1=O HIKITLLOKBXDAM-UHFFFAOYSA-N 0.000 description 1
- SAUXAZQHVCUVPP-UHFFFAOYSA-N 3-(5-chloro-1-methylindol-3-yl)-4-(5-methoxy-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound C1=C(Cl)C=C2C(C3=C(C(NC3=O)=O)C3=CN(C)C4=CC=C(C=C43)OC)=CN(C)C2=C1 SAUXAZQHVCUVPP-UHFFFAOYSA-N 0.000 description 1
- RYAUTVHKOZZQRF-UHFFFAOYSA-N 3-(6-amino-1-methylindol-3-yl)-4-(1,6-dimethylindol-3-yl)pyrrole-2,5-dione Chemical compound NC1=CC=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)C)=CN(C)C2=C1 RYAUTVHKOZZQRF-UHFFFAOYSA-N 0.000 description 1
- WDKCMFLCLIJSHL-UHFFFAOYSA-N 3-(6-amino-1-methylindol-3-yl)-4-(1-methyl-6-methylsulfanylindol-3-yl)pyrrole-2,5-dione Chemical compound NC1=CC=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)SC)=CN(C)C2=C1 WDKCMFLCLIJSHL-UHFFFAOYSA-N 0.000 description 1
- ZKSVMVQOZGPIAY-UHFFFAOYSA-N 3-(6-chloro-1-methylindol-3-yl)-4-(5-methoxy-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound ClC1=CC=C2C(C3=C(C(NC3=O)=O)C3=CN(C)C4=CC=C(C=C43)OC)=CN(C)C2=C1 ZKSVMVQOZGPIAY-UHFFFAOYSA-N 0.000 description 1
- YHDSCEWSGZZSCR-UHFFFAOYSA-N 3-(6-chloro-1-methylindol-3-yl)-4-(6-methoxy-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound ClC1=CC=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)OC)=CN(C)C2=C1 YHDSCEWSGZZSCR-UHFFFAOYSA-N 0.000 description 1
- LHLWPXGBFGNKPZ-UHFFFAOYSA-N 3-(6-ethoxy-1-methylindol-3-yl)-4-(1-methyl-6-nitroindol-3-yl)pyrrole-2,5-dione Chemical compound [O-][N+](=O)C1=CC=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)OCC)=CN(C)C2=C1 LHLWPXGBFGNKPZ-UHFFFAOYSA-N 0.000 description 1
- ODWRMQSOHHUGFB-UHFFFAOYSA-N 3-(6-ethoxy-1-methylindol-3-yl)-4-(4-fluoro-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound C1=CC(F)=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)OCC)=CN(C)C2=C1 ODWRMQSOHHUGFB-UHFFFAOYSA-N 0.000 description 1
- KAJPXTXSWZVCAV-UHFFFAOYSA-N 3-(6-ethoxy-1-methylindol-3-yl)-4-(5-methoxy-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound C1=C(OC)C=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)OCC)=CN(C)C2=C1 KAJPXTXSWZVCAV-UHFFFAOYSA-N 0.000 description 1
- AQOALQIVYNLHDJ-UHFFFAOYSA-N 3-(6-fluoro-1-methylindol-3-yl)-4-(1-methyl-6-nitroindol-3-yl)pyrrole-2,5-dione Chemical compound C12=CC=C(F)C=C2N(C)C=C1C1=C(C=2C3=CC=C(C=C3N(C)C=2)[N+]([O-])=O)C(=O)NC1=O AQOALQIVYNLHDJ-UHFFFAOYSA-N 0.000 description 1
- SIHUCQHLTHLODJ-UHFFFAOYSA-N 3-(6-fluoro-1-methylindol-3-yl)-4-(6-methoxy-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound FC1=CC=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)OC)=CN(C)C2=C1 SIHUCQHLTHLODJ-UHFFFAOYSA-N 0.000 description 1
- MLDCTVQCUWKAOG-UHFFFAOYSA-N 3-(6-methoxy-1-methylindol-3-yl)-4-[1-methyl-6-(methylamino)indol-3-yl]pyrrole-2,5-dione Chemical compound COC1=CC=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)NC)=CN(C)C2=C1 MLDCTVQCUWKAOG-UHFFFAOYSA-N 0.000 description 1
- OUCNDEVWCWRBQK-UHFFFAOYSA-N 3-[4-(1,6-dimethylindol-3-yl)-2,5-dioxopyrrol-3-yl]-1-methylindole-6-carbonitrile Chemical compound N#CC1=CC=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)C)=CN(C)C2=C1 OUCNDEVWCWRBQK-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- JZOSXTYDJPHXQD-UHFFFAOYSA-N 4-bromo-1-methylindole Chemical compound C1=CC=C2N(C)C=CC2=C1Br JZOSXTYDJPHXQD-UHFFFAOYSA-N 0.000 description 1
- UAUJZFNYIBXEDG-UHFFFAOYSA-N 5-chloro-1-methylindole Chemical compound ClC1=CC=C2N(C)C=CC2=C1 UAUJZFNYIBXEDG-UHFFFAOYSA-N 0.000 description 1
- PXHJDPPKNUGKPM-UHFFFAOYSA-N 6-bromo-1-methylindole Chemical compound C1=C(Br)C=C2N(C)C=CC2=C1 PXHJDPPKNUGKPM-UHFFFAOYSA-N 0.000 description 1
- YDLOPHRVGMIZDX-UHFFFAOYSA-N 6-chloro-1-methylindole Chemical compound C1=C(Cl)C=C2N(C)C=CC2=C1 YDLOPHRVGMIZDX-UHFFFAOYSA-N 0.000 description 1
- PRGVQKFCKJOOCV-UHFFFAOYSA-N 6-iodo-1-methylindole Chemical compound C1=C(I)C=C2N(C)C=CC2=C1 PRGVQKFCKJOOCV-UHFFFAOYSA-N 0.000 description 1
- COKWSWGGWUDCPA-UHFFFAOYSA-N 6-methoxy-1-methyl-2,3-dihydroindole Chemical compound COC1=CC=C2CCN(C)C2=C1 COKWSWGGWUDCPA-UHFFFAOYSA-N 0.000 description 1
- VTJXLVGZNOINAD-UHFFFAOYSA-N 6-methoxy-1-methylindole Chemical compound COC1=CC=C2C=CN(C)C2=C1 VTJXLVGZNOINAD-UHFFFAOYSA-N 0.000 description 1
- WRHNJAIUBFJMEM-UHFFFAOYSA-N 6-methoxy-1-methylindole-3-carbaldehyde Chemical compound COC1=CC=C2C(C=O)=CN(C)C2=C1 WRHNJAIUBFJMEM-UHFFFAOYSA-N 0.000 description 1
- QJRWYBIKLXNYLF-UHFFFAOYSA-N 6-methoxy-1h-indole Chemical compound COC1=CC=C2C=CNC2=C1 QJRWYBIKLXNYLF-UHFFFAOYSA-N 0.000 description 1
- XBTHQAKYJGTLRT-UHFFFAOYSA-N 6-methylsulfanyl-1h-indole Chemical compound CSC1=CC=C2C=CNC2=C1 XBTHQAKYJGTLRT-UHFFFAOYSA-N 0.000 description 1
- OJPNRJVMABFYLM-UHFFFAOYSA-N 6-methylsulfanyl-1h-indole-2-carboxylic acid Chemical compound CSC1=CC=C2C=C(C(O)=O)NC2=C1 OJPNRJVMABFYLM-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- MYJCBACFKUPWDC-UHFFFAOYSA-N CN1C=C(C2=CC=C(C=C12)N)C=1C(NC(C1C1=CN(C2=CC(=CC=C12)N)C)=O)=O.C(C)(=O)NC1=CC=C2C(=CN(C2=C1)C)C1=C(C(NC1=O)=O)C1=CN(C2=CC(=CC=C12)NC(C)=O)C Chemical compound CN1C=C(C2=CC=C(C=C12)N)C=1C(NC(C1C1=CN(C2=CC(=CC=C12)N)C)=O)=O.C(C)(=O)NC1=CC=C2C(=CN(C2=C1)C)C1=C(C(NC1=O)=O)C1=CN(C2=CC(=CC=C12)NC(C)=O)C MYJCBACFKUPWDC-UHFFFAOYSA-N 0.000 description 1
- UCWRXUUUISDKNA-UHFFFAOYSA-N CN1C=C(C2=CNC=C2C2=CN(C)C3=CC(F)=CC=C23)C2=CC=C(N)C=C12 Chemical compound CN1C=C(C2=CNC=C2C2=CN(C)C3=CC(F)=CC=C23)C2=CC=C(N)C=C12 UCWRXUUUISDKNA-UHFFFAOYSA-N 0.000 description 1
- AUPXBVDHVRZMIB-UHFFFAOYSA-M C[Mg]I Chemical group C[Mg]I AUPXBVDHVRZMIB-UHFFFAOYSA-M 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- UTUUFPDABVTOCO-UHFFFAOYSA-N Cl.NN1C(C(=C(C1=O)C=1NC2=CC=CC=C2C1)C=1NC2=CC=CC=C2C1)=O Chemical compound Cl.NN1C(C(=C(C1=O)C=1NC2=CC=CC=C2C1)C=1NC2=CC=CC=C2C1)=O UTUUFPDABVTOCO-UHFFFAOYSA-N 0.000 description 1
- 229940126062 Compound A Drugs 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229910004373 HOAc Inorganic materials 0.000 description 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 1
- 241000243251 Hydra Species 0.000 description 1
- LELOWRISYMNNSU-UHFFFAOYSA-N Hydrocyanic acid Natural products N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- 235000010650 Hyssopus officinalis Nutrition 0.000 description 1
- 240000001812 Hyssopus officinalis Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- XOBKSJJDNFUZPF-UHFFFAOYSA-N Methoxyethane Chemical compound CCOC XOBKSJJDNFUZPF-UHFFFAOYSA-N 0.000 description 1
- 241001553014 Myrsine salicina Species 0.000 description 1
- MGBGEQVBTQRMRZ-UHFFFAOYSA-N N-(1-methylindol-6-yl)acetamide Chemical compound C(C)(=O)NC1=CC=C2C=CN(C2=C1)C MGBGEQVBTQRMRZ-UHFFFAOYSA-N 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical class OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229920003081 Povidone K 30 Polymers 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Substances CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 1
- 208000011191 Pulmonary vascular disease Diseases 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical class [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 229910000102 alkali metal hydride Inorganic materials 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000012223 aqueous fraction Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- PUJDIJCNWFYVJX-UHFFFAOYSA-N benzyl carbamate Chemical compound NC(=O)OCC1=CC=CC=C1 PUJDIJCNWFYVJX-UHFFFAOYSA-N 0.000 description 1
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000007963 capsule composition Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000013058 crude material Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 150000004683 dihydrates Chemical class 0.000 description 1
- BGRWYRAHAFMIBJ-UHFFFAOYSA-N diisopropylcarbodiimide Natural products CC(C)NC(=O)NC(C)C BGRWYRAHAFMIBJ-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- KFKXPBNINRAMLZ-UHFFFAOYSA-N hydroxyarsenic Chemical compound [As]O KFKXPBNINRAMLZ-UHFFFAOYSA-N 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- CFHGBZLNZZVTAY-UHFFFAOYSA-N lawesson's reagent Chemical compound C1=CC(OC)=CC=C1P1(=S)SP(=S)(C=2C=CC(OC)=CC=2)S1 CFHGBZLNZZVTAY-UHFFFAOYSA-N 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910001507 metal halide Inorganic materials 0.000 description 1
- 150000005309 metal halides Chemical class 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 150000004681 metal hydrides Chemical class 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- DSOVBLHCROGBFQ-UHFFFAOYSA-N methyl 1-methyl-3-[4-(1-methyl-6-nitroindol-3-yl)-2,5-dioxopyrrol-3-yl]indole-6-carboxylate Chemical compound [O-][N+](=O)C1=CC=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)C(=O)OC)=CN(C)C2=C1 DSOVBLHCROGBFQ-UHFFFAOYSA-N 0.000 description 1
- YWHJNIAFMIGSHV-UHFFFAOYSA-N methyl 2-azido-3-(4-methylsulfanylphenyl)prop-2-enoate Chemical compound COC(=O)C(N=[N+]=[N-])=CC1=CC=C(SC)C=C1 YWHJNIAFMIGSHV-UHFFFAOYSA-N 0.000 description 1
- RXYCUKSOYJWGPE-UHFFFAOYSA-N methyl 2-azidoacetate Chemical compound COC(=O)CN=[N+]=[N-] RXYCUKSOYJWGPE-UHFFFAOYSA-N 0.000 description 1
- IBPIJISCEZWTFZ-UHFFFAOYSA-N methyl 3-(2-chloro-2-oxoacetyl)-1-methylindole-6-carboxylate Chemical compound COC(=O)C1=CC=C2C(C(=O)C(Cl)=O)=CN(C)C2=C1 IBPIJISCEZWTFZ-UHFFFAOYSA-N 0.000 description 1
- 229940050176 methyl chloride Drugs 0.000 description 1
- ZGEGCLOFRBLKSE-UHFFFAOYSA-N methylene hexane Natural products CCCCCC=C ZGEGCLOFRBLKSE-UHFFFAOYSA-N 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- FEQCRBPJMWBSIN-UHFFFAOYSA-N n-[3-[4-(6-methoxy-1-methylindol-3-yl)-2,5-dioxopyrrol-3-yl]-1-methylindol-6-yl]formamide Chemical compound O=CNC1=CC=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)OC)=CN(C)C2=C1 FEQCRBPJMWBSIN-UHFFFAOYSA-N 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 description 1
- CYQAYERJWZKYML-UHFFFAOYSA-N phosphorus pentasulfide Chemical compound S1P(S2)(=S)SP3(=S)SP1(=S)SP2(=S)S3 CYQAYERJWZKYML-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- UHXUUGXBVISQOH-UHFFFAOYSA-N propan-2-yl 2-(5-methoxy-1-methylindol-3-yl)ethanimidate;hydrochloride Chemical compound Cl.COC1=CC=C2N(C)C=C(CC(=N)OC(C)C)C2=C1 UHXUUGXBVISQOH-UHFFFAOYSA-N 0.000 description 1
- NXSKAFXOBAPOFO-UHFFFAOYSA-N propan-2-yl 2-(6-methoxy-1-methylindol-3-yl)ethanimidate;hydrochloride Chemical compound Cl.COC1=CC=C2C(CC(=N)OC(C)C)=CN(C)C2=C1 NXSKAFXOBAPOFO-UHFFFAOYSA-N 0.000 description 1
- NURWYCYSWCINFO-UHFFFAOYSA-N propan-2-yl ethanimidate;hydrochloride Chemical compound Cl.CC(C)OC(C)=N NURWYCYSWCINFO-UHFFFAOYSA-N 0.000 description 1
- 229940095574 propionic acid Drugs 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 108700002400 risuteganib Proteins 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 238000003797 solvolysis reaction Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000007916 tablet composition Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- BWNVTTNBDRHDLW-UHFFFAOYSA-N thiaphosphetane Chemical compound C1CSP1 BWNVTTNBDRHDLW-UHFFFAOYSA-N 0.000 description 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2207896P | 1996-07-29 | 1996-07-29 | |
| US60/022,078 | 1996-07-29 | ||
| US4849697P | 1997-06-03 | 1997-06-03 | |
| US60/048,496 | 1997-06-03 | ||
| PCT/EP1997/003888 WO1998004551A1 (en) | 1996-07-29 | 1997-07-19 | Substituted bisindolylmaleimides for the inhibition of cell proliferation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000516588A true JP2000516588A (ja) | 2000-12-12 |
| JP2000516588A5 JP2000516588A5 (cg-RX-API-DMAC10.html) | 2005-03-10 |
Family
ID=26695475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10508452A Ceased JP2000516588A (ja) | 1996-07-29 | 1997-07-19 | 細胞増殖阻害のための置換ビスインドリルマレイミド |
Country Status (20)
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006502115A (ja) * | 2002-07-12 | 2006-01-19 | イーライ・リリー・アンド・カンパニー | ２，５−ジオン−３−（１−メチル−１ｈ−インドール−３−イル）−４−［１−（ピリジン−２−イルメチル）ピペリジン−４−イル］−１ｈ−インドール−３−イル］−１ｈ−ピロール一塩酸塩の結晶 |
| JP2010513386A (ja) * | 2006-12-19 | 2010-04-30 | ノバルティス アーゲー | キナーゼ阻害剤としてのインドリルマレイミド誘導体 |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1064279B1 (en) * | 1998-03-17 | 2003-06-25 | F.Hoffmann-La Roche Ag | Substituted bisindolylmaleimides for the inhibition of cell proliferation |
| US6350786B1 (en) * | 1998-09-22 | 2002-02-26 | Hoffmann-La Roche Inc. | Stable complexes of poorly soluble compounds in ionic polymers |
| EP1224181B1 (en) * | 1999-10-12 | 2003-12-03 | F. Hoffmann-La Roche Ag | Substituted pyrroles as antiproliferative agents for the treatment of cancer |
| US6559164B1 (en) | 1999-10-12 | 2003-05-06 | Hoffmann-La Roche Inc. | Substituted pyrroles suitable for continuous infusion |
| US6313143B1 (en) * | 1999-12-16 | 2001-11-06 | Hoffmann-La Roche Inc. | Substituted pyrroles |
| US6281356B1 (en) | 1999-12-22 | 2001-08-28 | Hoffmann-La Roche Inc. | Substituted pyrroles |
| US6326501B1 (en) * | 2000-04-19 | 2001-12-04 | Hoffmann-La Roche Inc. | Methylation of indole compounds using dimethyl carbonate |
| US7129250B2 (en) * | 2000-05-19 | 2006-10-31 | Aegera Therapeutics Inc. | Neuroprotective and anti-proliferative compounds |
| CA2308994A1 (en) * | 2000-05-19 | 2001-11-19 | Aegera Therapeutics Inc. | Neuroprotective compounds |
| TW201041580A (en) | 2001-09-27 | 2010-12-01 | Alcon Inc | Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma |
| MXPA04004026A (es) * | 2001-10-29 | 2004-07-08 | Nektar Therapeutics Al Corp | Conjugados polimericos de inhibidores de la proteina quinasa c. |
| RS51826B (sr) | 2005-02-09 | 2012-02-29 | Arqule Inc. | Maleimid derivati, farmaceutske kompozicije i postupak lečenja kancera |
| AU2008268613A1 (en) | 2007-06-22 | 2008-12-31 | Arqule, Inc. | Quinazolinone compounds and methods of use thereof |
| EP2392574B1 (en) | 2007-06-22 | 2013-12-18 | ArQule, Inc. | Indolyl pyrrolidines for the treatment of cancer |
| CA2690799C (en) * | 2007-06-22 | 2015-06-16 | Arqule, Inc. | Pyrrolidinone, pyrrolidine-2,5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer |
| GB201111427D0 (en) * | 2011-07-05 | 2011-08-17 | Amakem Nv | Novel bisindolylmaleimides, pan-pkc inhibitors |
| US20170209488A1 (en) | 2014-07-17 | 2017-07-27 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods for treating neuromuscular junction-related diseases |
| WO2016207366A1 (en) | 2015-06-26 | 2016-12-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of viral infections |
| CN105777751B (zh) * | 2016-04-26 | 2018-12-11 | 浙江工业大学 | 一种双芳基马来酰亚胺类化合物及其药学上可接受的盐及其制备方法和应用 |
| CN107973785B (zh) * | 2017-11-27 | 2019-12-31 | 浙江工业大学上虞研究院有限公司 | 一种用于检测银离子的荧光探针及其制备方法和应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ280738B6 (cs) | 1988-02-10 | 1996-04-17 | F. Hoffmann - La Roche And Co., Aktiengesellschaft | Substituované pyrroly, jejich použití pro výrobu léčiv a léčiva na jejich bázi |
| US5380746A (en) | 1989-05-05 | 1995-01-10 | Goedecke Aktiengesellschaft | Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| PT93947B (pt) * | 1989-05-05 | 1996-11-29 | Goedecke Ag | Processo para a preparacao de novos derivados de maleinimidas e de composicoes farmaceuticas que os contem |
| JPH0539289A (ja) | 1991-02-15 | 1993-02-19 | Masahiro Irie | 無水マレイン酸誘導体およびその製造方法 |
| JPH07504673A (ja) | 1992-03-20 | 1995-05-25 | ザ・ウエルカム・ファウンデーション・リミテッド | 抗ウイルス活性を有するインドール誘導体 |
| DE4217964A1 (de) | 1992-05-30 | 1993-12-02 | Goedecke Ag | Indolocarbazol-Imide und deren Verwendung |
-
1997
- 1997-07-15 PE PE1997000629A patent/PE91598A1/es not_active Application Discontinuation
- 1997-07-19 TR TR1999/00186T patent/TR199900186T2/xx unknown
- 1997-07-19 WO PCT/EP1997/003888 patent/WO1998004551A1/en not_active Ceased
- 1997-07-19 ES ES97918934T patent/ES2183163T3/es not_active Expired - Lifetime
- 1997-07-19 BR BR9711607A patent/BR9711607A/pt not_active IP Right Cessation
- 1997-07-19 AT AT97918934T patent/ATE224889T1/de not_active IP Right Cessation
- 1997-07-19 CA CA002262089A patent/CA2262089A1/en not_active Abandoned
- 1997-07-19 DK DK97918934T patent/DK0915870T3/da active
- 1997-07-19 JP JP10508452A patent/JP2000516588A/ja not_active Ceased
- 1997-07-19 KR KR1019997000711A patent/KR20000029640A/ko not_active Abandoned
- 1997-07-19 PT PT97918934T patent/PT915870E/pt unknown
- 1997-07-19 EP EP97918934A patent/EP0915870B1/en not_active Expired - Lifetime
- 1997-07-19 DE DE69715870T patent/DE69715870T2/de not_active Expired - Fee Related
- 1997-07-19 CN CN97196783A patent/CN1077571C/zh not_active Expired - Fee Related
- 1997-07-19 AU AU42963/97A patent/AU740011B2/en not_active Ceased
- 1997-07-22 AR ARP970103308A patent/AR007969A1/es unknown
- 1997-07-25 CO CO97042636A patent/CO4900054A1/es unknown
- 1997-07-25 HR HR60/048,496A patent/HRP970415A2/hr not_active Application Discontinuation
- 1997-07-29 MA MA24743A patent/MA24354A1/fr unknown
-
1998
- 1998-12-22 US US09/218,404 patent/US6228877B1/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006502115A (ja) * | 2002-07-12 | 2006-01-19 | イーライ・リリー・アンド・カンパニー | ２，５−ジオン−３−（１−メチル−１ｈ−インドール−３−イル）−４−［１−（ピリジン−２−イルメチル）ピペリジン−４−イル］−１ｈ−インドール−３−イル］−１ｈ−ピロール一塩酸塩の結晶 |
| JP2011144182A (ja) * | 2002-07-12 | 2011-07-28 | Eli Lilly & Co | ２，５−ジオン−３−（１−メチル−１ｈ−インドール−３−イル）−４−［１−（ピリジン−２−イルメチル）ピペリジン−４−イル］−１ｈ−インドール−３−イル］−１ｈ−ピロール一塩酸塩の結晶 |
| JP4771356B2 (ja) * | 2002-07-12 | 2011-09-14 | イーライ リリー アンド カンパニー | ２，５−ジオン−３−（１−メチル−１ｈ−インドール−３−イル）−４−［１−（ピリジン−２−イルメチル）ピペリジン−４−イル］−１ｈ−インドール−３−イル］−１ｈ−ピロール一塩酸塩の結晶 |
| JP2010513386A (ja) * | 2006-12-19 | 2010-04-30 | ノバルティス アーゲー | キナーゼ阻害剤としてのインドリルマレイミド誘導体 |
Also Published As
| Publication number | Publication date |
|---|---|
| MA24354A1 (fr) | 1998-07-01 |
| PT915870E (pt) | 2003-01-31 |
| CN1077571C (zh) | 2002-01-09 |
| CN1226248A (zh) | 1999-08-18 |
| DE69715870D1 (de) | 2002-10-31 |
| HRP970415A2 (en) | 1998-08-31 |
| PE91598A1 (es) | 1998-12-24 |
| EP0915870B1 (en) | 2002-09-25 |
| US6228877B1 (en) | 2001-05-08 |
| EP0915870A1 (en) | 1999-05-19 |
| AR007969A1 (es) | 1999-11-24 |
| DE69715870T2 (de) | 2003-06-18 |
| BR9711607A (pt) | 1999-08-24 |
| DK0915870T3 (da) | 2003-02-03 |
| ATE224889T1 (de) | 2002-10-15 |
| AU740011B2 (en) | 2001-10-25 |
| WO1998004551A1 (en) | 1998-02-05 |
| CA2262089A1 (en) | 1998-02-05 |
| KR20000029640A (ko) | 2000-05-25 |
| ES2183163T3 (es) | 2003-03-16 |
| TR199900186T2 (xx) | 1999-03-22 |
| CO4900054A1 (es) | 2000-03-27 |
| AU4296397A (en) | 1998-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2000516588A (ja) | 細胞増殖阻害のための置換ビスインドリルマレイミド | |
| US5057614A (en) | Substituted pyrroles | |
| JP2000516589A (ja) | 細胞増殖阻害のための置換ビスインドリルマレイミド | |
| HU207727B (en) | Process for peoducing maleinimide derivatives and pharmaceutical compositions containing them | |
| JP5746821B2 (ja) | ピラゾリルベンゾイミダゾール誘導体、これらを含有する組成物及びこれらの使用 | |
| HUT76787A (en) | Pyrrole ring containing tetracyclic compounds, process for their preparation and pharmaceutical compositions containing them | |
| AU782920B2 (en) | Substituted pyrroles | |
| USRE36736E (en) | Substituted pyrroles | |
| AU739704B2 (en) | Substituted pyrroles | |
| AU675641B2 (en) | Imidazole, triazole and tetrazole derivatives | |
| MXPA99001027A (en) | Substituted bisindolylmaleimides for the inhibition of cell proliferation | |
| MXPA99000961A (en) | Substituted bisindolylmaleimides for the inhibition of cell proliferation | |
| MXPA99001026A (en) | Substituted bisindolylmaleimides for the inhibition of cell proliferation | |
| EP2864334A1 (en) | Synthesis of thiosemicarbazides and triazoles derived from etodolac |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040618 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040618 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080115 |
|
| A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20080617 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080805 |